BSEInsider Trading / SAST26 Sept 2026 · 26 Sept 2026, 08:41 pm
Closure of Trading window for the approval of unaudited financials statements Quarter and half year ended September 30, 2026.
Arvaya Healthcare Ltd · 524723
✦ AI SummaryResults
Arvaya Healthcare Ltd has closed its trading window for the approval of unaudited financial statements for the second quarter and half year ended September 30, 2026, as per SEBI regulations.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Arvaya Healthcare Ltd - 524723 - Closure of Trading Window
Attachments (1)
📄pdf
Download →
da98a6f7-4cbb-4a37-9fbb-ff57d0c5a959.pdf
View document text
Date: September 26, 2026
BSE Limited,
Phiroze Jeejeebhoy Towers,
Dalal Street,
Mumbai - 400 001
Scrip Code: 524723
Sub: Intimation for Closure of Trading Window in terms of the SEBI (Prohibition of Insider
Trading) Regulations, 2015.
This is to inform you that, pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015, as
amended, the trading window for dealing in shares of the Company by its Directors, Promoters, Promoter
Group, Key Managerial Personnel, Designated Persons, their Immediate Relatives and connected Persons
shall remain closed with effect from Thursday, 01st October 2026 till 48 hours after the declaration of
Unaudited Financial Results of the Company for the Second Quarter and Half Year ending as on 30th
September 2026.
The date of the Board Meeting of the Company for the for declaration of unaudited Financial Results for
the Second Quarter ended September 30, 2026 will be intimated separately.
Further, as per SEBI Circulars SEBI/HO/ISD/ISD-PoD-2/P/CIR/2023/12 dated 19th July 2023 and
SEBI/HO/ISD/ISD-PoD-2/P/CIR/2025/55 dated 21st April 2025, in order to rationalize the compliance
requirement under Clause 4 of Schedule B read with Regulation 9 of PIT Regulations, to improve ease of
doing business and to prevent inadvertent non-compliance of provisions of PIT Regulations by DPs, SEBI
has laid down a framework for developing a system to restrict the trading by Designated Persons (DPs) by
way of freezing the PAN at security level during the Trading Window closure period. Accordingly, PAN of
all the Designated Persons of the Company and their relatives is frozen during the Trading Window closure
period.
The above is for your information and record, you are requested to disseminate the above information on
your respective websites.
Thanking you.
For ARVAYA HEALTHCARE LIMITED
(FORMERLY KNOWN AS BIJOY HANS LIMITED)
KAUSHAL SHAH
MANAGING DIRECTOR
DIN: 02175130
Place: Sangli